======= C2orf48 ======= == Gene Information == * **Official Symbol**: RRM2 * **Official Name**: ribonucleotide reductase regulatory subunit M2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6241|6241]] * **UniProt**: [[https://www.uniprot.org/uniprot/P31350|P31350]] * **Interactions**: [[https://thebiogrid.org/search.php?search=C2orf48&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C2orf48|Open PubMed]] * **OMIM**: [[https://omim.org/entry/180390|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. Inhibits Wnt signaling. |Ribonuc red sm| |ribonucleoside-diphosphate reductase complex| |ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor| |ferric iron binding| |deoxyribonucleotide biosynthetic process| |regulation of transcription involved in G1/S transition of mitotic cell cycle| |nucleobase-containing small molecule interconversion| |protein heterotetramerization| |deoxyribonucleotide metabolic process| |negative regulation of G0 to G1 transition| |regulation of G0 to G1 transition| |protein heterooligomerization| |G1/S transition of mitotic cell cycle| |cell cycle G1/S phase transition| |protein tetramerization| |DNA replication| |nucleotide biosynthetic process| |nucleoside phosphate biosynthetic process| |mitotic cell cycle phase transition| |cell cycle phase transition| |negative regulation of cell cycle process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |protein complex oligomerization| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |negative regulation of cell cycle| |mitotic cell cycle process| |carbohydrate derivative biosynthetic process| |mitotic cell cycle| |regulation of cell cycle process| |protein homodimerization activity| |organophosphate metabolic process| |oxidation-reduction process| |cell cycle process| |carbohydrate derivative metabolic process| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |regulation of cell cycle| |organic cyclic compound biosynthetic process| |cell cycle| |protein-containing complex assembly| |cellular nitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |small molecule metabolic process| |macromolecule biosynthetic process| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp359|FK-506 30μM R07 exp359]]|1.78| |[[:results:exp372|Ibrutinib 1μM R07 exp372]]|2.07| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 737/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|28/28| |bone|26/26| |breast|33/33| |central nervous system|55/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|16/16| |kidney|21/21| |liver|20/20| |lung|74/75| |lymphocyte|16/16| |ovary|26/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|24/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|29/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12977 * **Expression level (log2 read counts)**: 2.59 {{:chemogenomics:nalm6 dist.png?nolink |}}